RAGE polymorphisms are not associated with risk of multiple sclerosis in Iranian population

被引:0
作者
Safari, Mohammad Reza [1 ]
Noroozi, Rezvan [2 ]
Azari, Iman [3 ]
Mazdeh, Mehrdokht [4 ]
Taheri, Mohammad [5 ]
Ghafouri-Fard, Soudeh [3 ]
机构
[1] Hamadan Univ Med Sci, Sch Para Med, Dept Med Lab Sci, Hamadan, Iran
[2] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran
[4] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran
[5] Shahid Beheshti Univ Med Sci, Urogenital Stem Cell Res Ctr, Tehran, Iran
关键词
RAGE; AGER; Multiple sclerosis; GLYCATION END-PRODUCTS; SOLUBLE RECEPTOR; EXPRESSION;
D O I
10.1016/j.genrep.2019.100400
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Multiple sclerosis (MS) as a chronic demyelinating disorder has been related with advanced glycoxidation end products (AGEs). Receptor for AGEs (RAGE) in encoded by a gene which contains several functional single nucleotide polymorphisms (SNPs). In this investigation, we have genotyped two SNPs within this gene in 376 MS patients and 400 healthy individuals. No significant difference was detected in genotype and allele frequencies of rs184003 between cases and controls. Primarily, the rs1800625 was associated with MS risk in recessive model. However, after correction for multiple comparison, the association did not reach the level of significance. The four estimated haplotypes were similarly distributed between MS patients and healthy subjects. Consequently, our study excludes the role of mentioned SNPs in conferring risk of MS in Iranian patients. However, other SNPs within this gene might influence the risk of MS. So future genotyping of other functional variants within this gene are necessary to unravel the role of RAGE in MS.
引用
收藏
页数:4
相关论文
共 20 条
[1]   Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment [J].
Adamczyk-Sowa, Monika ;
Galiniak, Sabina ;
Zyracka, Ewa ;
Grzesik, Michalina ;
Naparlo, Katarzyna ;
Sowa, Pawel ;
Bartosz, Grzegorz ;
Sadowska-Bartosz, Izabela .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
[2]   Association between the Advanced Glycosylation End Product-Specific Receptor Gene and Cardiovascular Death in Older Men [J].
Biros, Erik ;
Moran, Corey S. ;
Norman, Paul E. ;
Hankey, Graeme J. ;
Yeap, Bu B. ;
Almeida, Osvaldo P. ;
Flicker, Leon ;
White, Richard ;
Jones, Rhondda ;
Golledge, Jonathan .
PLOS ONE, 2015, 10 (07)
[3]   RAGE (receptor for advanced glycation end products): a central player in the inflammatory response [J].
Chavakis, T ;
Bierhaus, A ;
Nawroth, PP .
MICROBES AND INFECTION, 2004, 6 (13) :1219-1225
[4]   Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases [J].
Chuah, Yaw Kuang ;
Basir, Rusliza ;
Talib, Herni ;
Tie, Tung Hing ;
Nordin, Norshariza .
INTERNATIONAL JOURNAL OF INFLAMMATION, 2013, 2013
[5]  
Eftekharian Mohammad Mahdi, 2015, Human Antibodies, V24, P17, DOI 10.3233/HAB-150289
[6]  
Glasnovic A, 2014, DECREASED LEVEL SRAG
[7]  
Kalousova M, 2005, Prague Med Rep, V106, P167
[8]  
Nemati Shirin, 2015, Human Antibodies, V24, P33, DOI 10.3233/HAB-160291
[9]   Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria" [J].
Polman, CH ;
Reingold, SC ;
Edan, G ;
Filippi, M ;
Hartung, HP ;
Kappos, L ;
Lublin, FD ;
Metz, LM ;
McFarland, HF ;
O'Connor, PW ;
Sandberg-Wollheim, M ;
Thompson, AJ ;
Weinshenker, BG ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2005, 58 (06) :840-846
[10]   Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a [J].
Rahimi, Mahnoosh ;
Afjeh, Sarah Saadat Aghabozorg ;
Omrani, Mir Davood ;
Arsang-Jang, Shahram ;
Ganji, Maziar ;
Noroozi, Rezvan ;
Taheri, Mohammad ;
Ghafouri-Fard, Soudeh .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (02) :561-567